Maysa Labs Profile
Key Indicators
- Authorised Capital ₹ 4.50 Cr
- Paid Up Capital ₹ 4.50 Cr
- Company Age 11 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 17.54 Cr
- Revenue Growth %
- Profit Growth -1.92%
- Ebitda 12.50%
- Net Worth -0.22%
- Total Assets -0.15%
About Maysa Labs
Maysa Labs Private Limited (MLPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 March 2013 and has a history of 11 years and ten months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.50 Cr and a paid-up capital of Rs 4.50 Cr.
The company currently has active open charges totaling ₹17.54 Cr.
Vaidula Srinivas, Suguna Chadalavada, and Ramesh Chadalavada serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24233TG2013PTC086517
-
Company No.
086517
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Mar 2013
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Maysa Labs?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vaidula Srinivas
|
Director | 20-Apr-2013 | Current |
|
Suguna Chadalavada
|
Director | 20-Mar-2013 | Current |
|
Ramesh Chadalavada
|
Additional Director | 17-Jan-2019 | Current |
Financial Performance of Maysa Labs.
Maysa Labs Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 1.92% decrease in profit. The company's net worth dipped by a decrease of 0.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Maysa Labs?
In 2020, Maysa Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Peonies International LimitedRamesh Chadalavada is a mutual person
Charges (Loans)
₹17.54 Cr
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 17.54 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jul 2013 | Canara Bank | ₹17.54 Cr | Open |
How Many Employees Work at Maysa Labs?
Unlock and access historical data on people associated with Maysa Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maysa Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maysa Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
